[Ip-health] New Tufts study on R&D costs
Ellen 't Hoen
elisabeththoen at gmail.com
Fri Nov 14 22:28:35 PST 2014
I wanted to say 2.1 Bn but that one is taken so 2.2 Bn
If I win I will double the amount (the 50 not the 2.2Bn) and donate it back to KEI.
Ellen 't Hoen, LLM
Medicines Law & Policy
phone FR: +33 (0)695048388
phone NL: +31 (0) 637530700
e-mail: ellenthoen.ip at gmail.com
On 14 Nov 2014, at 18:35, Jamie Love <james.love at keionline.org> wrote:
> Next week, a new version of the Tufts study on R&D costs will be released.
> KEI will give $50 to the person who comes the closed in predicting the new
> figure for the cost of R&D for the lead indication of a new chemical entity.
> An abstract of the earlier 2003 study,"The price of innovation: new
> estimates of drug development costs" is available here:
> The 2003 study put the number at $802 million (not $800 million, but $802
> million), in 2000 dollars.
> As I said, $50 for the closest estimate, published on IP-Health, before the
> new number is announced (or leaked).
> James Love. Knowledge Ecology International
> KEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile:
> +41.76.413.6584, twitter.com/jamie_love
> Ip-health mailing list
> Ip-health at lists.keionline.org
More information about the Ip-health